Rare diseases
Investigational molecules
Locations
Corporation Trust Center, 1209 North Orange Street, 19801-1120, United States
The sponsor’s clinical research is centered on non-permanent atrial fibrillation, with attention to conditions that affect heart rhythm stability and recurrence of arrhythmia.
Research activity in this area reflects interest in therapies aimed at restoring and maintaining cardiac rhythm in patients with intermittent forms of atrial fibrillation.
Xyra LLC runs clinical trials in conditions such as Atrial fibrillation, among others.
Clinical trials run by this sponsor – those enrolling participants first.
A study to evaluate the safety and effectiveness of budiodarone tartrate in patients with non-permanent atrial fibrillation
PolandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
